Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level
Authors:
Open Access
- 29 September 2020
- journal article
- research article
- Published by Frontiers Media SA in Journal of Pharmacy & Pharmaceutical Sciences
- Vol. 23, 333-356
Abstract
Transporters are large membrane proteins, which control the passage of various compounds through biological membranes. These proteins are divided into uptake and efflux transporters and play an important role in the toxicokinetics of many endobiotics and xenobiotics. The uptake transporters facilitate the absorption of these compounds from the blood into the proximal tubular cells, while the efflux transporters eliminate these compounds into tubular fluid (urine). Overall, the uptake is performed by the superfamily solute carrier (SLC) transporters, which are, mostly, located in the basolateral membrane. The organic anion transporters (OATs; SLC22), the organic cation transporters (OCTs; SLC22), the organic cation/carnitine transporters (OCTNs), and the organic anion transporting polypeptides (OATP; SLC21/SLCO) are some examples of uptake transporters of the SLC superfamily. On the other hand, the superfamily ATP-binding cassette (ABC) transporters carry out the elimination of the substances through the apical membrane of the proximal tubular cells. The multidrug resistance proteins 1 (MDR; ABCB), the multi resistance protein (MRP2; ABCC) and the breast cancer resistance protein (BCRP, ABCG) along with the multidrug and toxin extrusion (MATE), which is an SLC transporter, carry out the substance efflux of the cell, However, uptake transporters seem to be more efficient than efflux transporters, leading to an accumulation of compounds in proximal tubular cells and, consequently, to renal damage. The accumulation of compounds can also occur due to variations in the number of transporters that exist due to differences in sex, age, genetic polymorphisms and epigenetics. Furthermore, some substances can inhibit, induce or, eventually, activate these transporters, with consequent drug-drug interactions (DDIs) as a result of alterations on the toxicokinetics of xenobiotics, leading to an increase of their accumulation and, consequently, to renal damage. These compounds may be exogenous, such as antibiotics, antivirals, cisplatin, metals, herbicides, mycotoxins and drugs; or endogenous, like uric acid, bile acids, bilirubin conjugates and conjugated steroids. Thus, in this review, we will focus on the accumulation of exogenous compounds due to variations on renal transporters and the consequent biological effects caused by them.Keywords
This publication has 99 references indexed in Scilit:
- Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat KidneyJournal of Pharmaceutical Sciences, 2016
- Sub‐chronic exposure to fluoride impacts the response to a subsequent nephrotoxic treatment with gentamicinJournal of Applied Toxicology, 2015
- Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in AdultsJAMA, 2015
- Prevention of Nephrotoxicity Induced by Cyclosporine‐A: Role of AntioxidantsJournal of Cellular Biochemistry, 2014
- P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicityArchives of Toxicology, 2014
- Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquatArchives of Toxicology, 2014
- Ochratoxin A: Developmental and Reproductive Toxicity—An OverviewBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2013
- Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy2010
- Selective and non‐selective non‐steroidal anti‐inflammatory drugs and the risk of acute kidney injuryPharmacoepidemiology and Drug Safety, 2009
- Paraquat-induced gene expression in rat kidneyArchives of Toxicology, 2006